Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug approvals
Pharma
Regulatory tracker: FDA signs off on Incyte's Jakafi XR
Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Angus Liu
,
Eric Sagonowsky
,
Fraiser Kansteiner
,
Kevin Dunleavy
,
Zoey Becker
May 4, 2026 2:56pm
Pfizer, Arvinas' breast cancer med wins FDA approval
May 1, 2026 3:50pm
FDA approves leucovorin without clinical trial—but not for autism
Mar 10, 2026 9:00am
Drug approvals went from crawl to sprint in 2025
Jan 16, 2026 10:00am
2025 approvals: Biopharma delivered 55 new drugs, biologics
Jan 5, 2026 3:00am
Vanda, Agios score holiday season FDA approvals
Jan 2, 2026 11:33am